| Product | Detection Target Combinations | Approved Drugs (Cancer Types) | Clinical Trial Drugs (Cancer Types) |
|---|---|---|---|
| FRα Detection Kit | FRα | Somituximab (Elahere): platinum-resistant ovarian cancer (introduced by Huadong Medicine for patients with high FRα expression) | HDM2027(Huadong Medicine): Ovarian Cancer (Stage I) |